quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:00:44·87d
SECFiling
Armata Pharmaceuticals Inc. logo

Armata Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

ARMP· Armata Pharmaceuticals Inc.
Health Care
Original source

Companies

  • ARMP
    Armata Pharmaceuticals Inc.
    Health Care

Related

  • SEC21d
    Armata Pharmaceuticals Inc. filed SEC Form 8-K: Other Events
  • SEC29d
    SEC Form 10-K filed by Armata Pharmaceuticals Inc.
  • SEC29d
    Armata Pharmaceuticals Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
  • PR29d
    Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2025 Financial Results
  • SEC35d
    Armata Pharmaceuticals Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
  • PR35d
    Armata Pharmaceuticals Delays Announcement of Fourth Quarter and Full-Year 2025 Results and Provides Corporate Update
  • INSIDER37d
    Chief Business Officer Kyme Pierre covered exercise/tax liability with 1,030 shares, decreasing direct ownership by 10% to 9,461 units (SEC Form 4)
  • INSIDER37d
    Chief Executive Officer Birx Deborah covered exercise/tax liability with 4,919 shares, decreasing direct ownership by 2% to 212,458 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022